Author
Listed:
- Omar S. Ahmad
(Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University
McGill University)
- John A. Morris
(Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University
McGill University)
- Muhammad Mujammami
(Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University
McGill University)
- Vincenzo Forgetta
(Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University
McGill University)
- Aaron Leong
(Harvard Medical School)
- Rui Li
(Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University
McGill University
McGill University)
- Maxime Turgeon
(Epidemiology, Biostatistics and Occupational Health, and Human Genetics, McGill University)
- Celia M.T. Greenwood
(Epidemiology, Biostatistics and Occupational Health, and Human Genetics, McGill University)
- George Thanassoulis
(McGill University
McGill University)
- James B. Meigs
(Harvard Medical School)
- Robert Sladek
(McGill University
McGill University)
- J. Brent Richards
(Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University
McGill University
McGill University
King's College London)
Abstract
In observational studies, type-2 diabetes (T2D) is associated with an increased risk of coronary heart disease (CHD), yet interventional trials have shown no clear effect of glucose-lowering on CHD. Confounding may have therefore influenced these observational estimates. Here we use Mendelian randomization to obtain unconfounded estimates of the influence of T2D and fasting glucose (FG) on CHD risk. Using multiple genetic variants associated with T2D and FG, we find that risk of T2D increases CHD risk (odds ratio (OR)=1.11 (1.05–1.17), per unit increase in odds of T2D, P=8.8 × 10−5; using data from 34,840/114,981 T2D cases/controls and 63,746/130,681 CHD cases/controls). FG in non-diabetic individuals tends to increase CHD risk (OR=1.15 (1.00–1.32), per mmol·per l, P=0.05; 133,010 non-diabetic individuals and 63,746/130,681 CHD cases/controls). These findings provide evidence supporting a causal relationship between T2D and CHD and suggest that long-term trials may be required to discern the effects of T2D therapies on CHD risk.
Suggested Citation
Omar S. Ahmad & John A. Morris & Muhammad Mujammami & Vincenzo Forgetta & Aaron Leong & Rui Li & Maxime Turgeon & Celia M.T. Greenwood & George Thanassoulis & James B. Meigs & Robert Sladek & J. Brent, 2015.
"A Mendelian randomization study of the effect of type-2 diabetes on coronary heart disease,"
Nature Communications, Nature, vol. 6(1), pages 1-11, November.
Handle:
RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms8060
DOI: 10.1038/ncomms8060
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms8060. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.